The maltose ABC transporter in Lactococcus lactis facilitates high-level sensitivity to the circular bacteriocin garvicin ML

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 6, 2012, Pages 2908-2915

  Gabrielsen, Christina ^a   Brede, Dag A ^a   Hernández, Pablo E ^b   Nes, Ingolf F ^a   Diep, Dzung B ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BACTERIOCIN; GARVICIN ML; MALTOSE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CARBOHYDRATE METABOLISM; CHROMOSOME DELETION; CONTROLLED STUDY; DRUG SENSITIVITY; LACTOCOCCUS LACTIS; NONHUMAN; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; BACTERIOCINS; CARBOHYDRATE METABOLISM; GALACTOSE; LACTOCOCCUS LACTIS; MALTOSE; STARCH;

EID: 84861149628     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00314-12     Document Type: Article

References (60)

1. Andersson U, Molenaar D, Radstrom P, de Vos WM. 2005. Unity in organisation and regulation of catabolic operons in Lactobacillus plantarum, Lactococcus lactis and Listeria monocytogenes. Syst. Appl. Microbiol. 28:187-195. (Pubitemid 40461695)
2. Andersson U, Radstrom P. 2002. Physiological function of the maltose operon regulator, MalR, in Lactococcus lactis. BMC Microbiol. 2:28.
3. Arakawa K, et al. 2010. HPLC purification and re-evaluation of chemical identity of two circular bacteriocins, gassericin A and reutericin 6. Lett. Appl. Microbiol. 50:406-411.
4. Babasaki K, Takao T, Shimonishi Y, Kurahashi K. 1985. Subtilosin A, a new antibiotic peptide produced by Bacillus subtilis 168: isolation, structural analysis, and biogenesis. J. Biochem. 98:585-603. (Pubitemid 16216406)
5. Bieler S, Silva F, Belin D. 2010. The polypeptide core of microcin E492 stably associates with the mannose permease and interferes with mannose metabolism. Res. Microbiol. 161:706-710.
6. Borrero J, et al. 2011. Characterization of garvicin ML, a novel circular bacteriocin produced by Lactococcus garvieae DCC43, isolated from mallard ducks (Anas platyrhynchos). Appl. Environ. Microbiol. 77:369-373.
7. Bounaix S, Benachour A, Novel G. 1996. Presence of lactose genes and insertion sequences in plasmids of minor species of the genus Lactococcus. Appl. Environ. Microbiol. 62:1112-1115. (Pubitemid 26071493)
8. Brotz H, et al. 1998. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30:317-327. (Pubitemid 28480183)
9. Campelo AB, et al. 2011. The Lcn972 bacteriocin-encoding plasmid pBL1 impairs cellobiose metabolism in Lactococcus lactis. Appl. Environ. Microbiol. 77:7576-7585.
10. .Chopin A, Chopin MC, Moillo-Batt A, Langella P. 1984. Two plasmid-determined restriction and modification systems in Streptococcus lactis. Plasmid 11:260-263. (Pubitemid 14052047)
11. Conlan BF, Gillon AD, Craik DJ, Anderson MA. 2010. Circular proteins and mechanisms of cyclization. Biopolymers 94:573-583.
12. Cotter PD, Hill C, Ross RP. 2005. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3:777-788. (Pubitemid 41518738)
13. de Ruyter PG, Kuipers OP, de Vos WM. 1996. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl. Environ. Microbiol. 62:3662-3667. (Pubitemid 26329592)
14. Deutscher J. 2008. The mechanisms of carbon catabolite repression in bacteria. Curr. Opin. Microbiol. 11:87-93.
15. de Visser JA, Akkermans AD, Hoekstra RF, de Vos WM. 2004. Insertion-sequence-mediated mutations isolated during adaptation to growth and starvation in Lactococcus lactis. Genetics 168:1145-1157. (Pubitemid 40007338)
16. Diep DB, Skaugen M, Salehian Z, Holo H, Nes IF. 2007. Common mechanisms of target cell recognition and immunity for class II bacteriocins. Proc. Natl. Acad. Sci. U. S. A. 104:2384-2389. (Pubitemid 46391406)
17. Dobson A, Cotter PD, Ross RP, Hill C. 2012. Bacteriocin production: a probiotic trait? Appl. Environ. Microbiol. 78:1-6.
18. Draper LA, Ross RP, Hill C, Cotter PD. 2008. Lantibiotic immunity. Curr. Protein Pept. Sci. 9:39-49.
19. Drider D, Fimland G, Hechard Y, McMullen LM, Prevost H. 2006. The continuing story of class IIa bacteriocins. Microbiol. Mol. Biol. Rev. 70:564-582. (Pubitemid 43895038)
20. Elliott JA, Collins MD, Pigott NE, Facklam RR. 1991. Differentiation of Lactococcus lactis and Lactococcus garvieae from humans by comparison of whole-cell protein patterns. J. Clin. Microbiol. 29:2731-2734.
21. Fimland G, Johnsen L, Dalhus B, Nissen-Meyer J. 2005. Pediocin-like antimicrobial peptides (class IIa bacteriocins) and their immunity proteins: biosynthesis, structure, and mode of action. J. Pept. Sci. 11:688-696. (Pubitemid 41684255)
22. Galvez A, Maqueda M, Martinez-Bueno M, Valdivia E. 1991. Permeation of bacterial cells, permeation of cytoplasmic and artificial membrane vesicles, and channel formation on lipid bilayers by peptide antibiotic AS-48. J. Bacteriol. 173:886-892.
23. Gong X, Martin-Visscher LA, Nahirney D, Vederas JC, Duszyk M. 2009. The circular bacteriocin, carnocyclin A, forms anion-selective channels in lipid bilayers. Biochim. Biophys. Acta 1788:1797-1803.
24. Gravesen A, et al. 2002. High-level resistance to class IIa bacteriocins is associated with one general mechanism in Listeria monocytogenes. Microbiology 148:2361-2369.
25. Hechard Y, Sahl HG. 2002. Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria. Biochimie 84:545-557. (Pubitemid 35350886)
26. Holo H, Nes IF. 1989. High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl. Environ. Microbiol. 55:3119-3123. (Pubitemid 20002122)
27. Kalmokoff ML, Cyr TD, Hefford MA, Whitford MF, Teather RM. 2003. Butyrivibriocin AR10, a new cyclic bacteriocin produced by the ruminal anaerobe Butyrivibrio fibrisolvens AR10: characterization of the gene and peptide. Can. J. Microbiol. 49:763-773.
28. Kawai Y, Kemperman R, Kok J, Saito T. 2004. The circular bacteriocins gassericin A and circularin A. Curr. Protein Pept. Sci. 5:393-398. (Pubitemid 39200169)
29. Kawai Y, Saito T, Kitazawa H, Itoh T. 1998. Gassericin A; an uncommon cyclic bacteriocin produced by Lactobacillus gasseri LA39 linked at N- and C-terminal ends. Biosci. Biotechnol. Biochem. 62:2438-2440.
30. Kawulka K, et al. 2003. Structure of subtilosin A, an antimicrobial peptide from Bacillus subtilis with unusual posttranslational modifications linking cysteine sulfurs to alpha-carbons of phenylalanine and threonine. J. Am. Chem. Soc. 125:4726-4727. (Pubitemid 36505362)
31. Kelly WJ, Ward LJ, Leahy SC. 2010. Chromosomal diversity in Lactococcus lactis and the origin of dairy starter cultures. Genome Biol. Evol. 2:729-744.
32. Kjos M, et al. 2011. Target recognition, resistance, immunity and genome mining of class II bacteriocins from Gram-positive bacteria. Microbiology 157:3256-3267.
33. Kjos M, Nes IF, Diep DB. 2009. Class II one-peptide bacteriocins target a phylogenetically defined subgroup of mannose phosphotransferase systems on sensitive cells. Microbiology 155:2949-2961.
34. Kjos M, Salehian Z, Nes IF, Diep DB. 2010. An extracellular loop of the mannose phosphotransferase system component IIC is responsible for specific targeting by class IIa bacteriocins. J. Bacteriol. 192:5906-5913.
35. Kleerebezem M, Beerthuyzen MM, Vaughan EE, de Vos WM, Kuipers OP. 1997. Controlled gene expression systems for lactic acid bacteria: transferable nisin-inducible expression cassettes for Lactococcus, Leuconostoc, and Lactobacillus spp. Appl. Environ. Microbiol. 63:4581-4584. (Pubitemid 27485794)
36. Kramer NE, Van Hijum SAFT, Knol J, Kok J, Kuipers OP. 2006. Transcriptome analysis reveals mechanisms by which Lactococcus lactis acquires nisin resistance. Antimicrob. Agents. Chemother. 50:1753-1761.
37. Law J, et al. 1995. A system to generate chromosomal mutations in Lactococcus lactis which allows fast analysis of targeted genes. J. Bacteriol. 177:7011-7018.
38. Luesink EJ, van Herpen RE, Grossiord BP, Kuipers OP, de Vos WM. 1998. Transcriptional activation of the glycolytic las operon and catabolite repression of the gal operon in Lactococcus lactis are mediated by the catabolite control protein CcpA. Mol. Microbiol. 30:789-798. (Pubitemid 28528598)
39. Maqueda M, et al. 2004. Peptide AS-48: prototype of a new class of cyclic bacteriocins. Curr. Protein Pept. Sci. 5:399-416. (Pubitemid 39200170)
40. Maqueda M, et al. 2008. Genetic features of circular bacteriocins produced by Gram-positive bacteria. FEMS Microbiol. Rev. 32:2-22. (Pubitemid 350293913)
41. Marreddy RK, et al. 2011. The response of Lactococcus lactis to membrane protein production. PLoS One 6:e24060.
42. Martin-Visscher LA, Gong X, Duszyk M, Vederas JC. 2009. The three-dimensional structure of carnocyclinAreveals thatmanycircular bacteriocins share a common structural motif. J. Biol. Chem. 284:28674-28681.
43. Martin-Visscher LA, et al. 2008. Isolation and characterization of carnocyclin A, a novel circular bacteriocin produced by Carnobacterium maltaromaticum UAL307. Appl. Environ. Microbiol. 74:4756-4763.
44. Masuda Y, et al. 2011. Identification and characterization of leucocyclicin Q, a novel cyclic bacteriocin produced by Leuconostoc mesenteroides TK41401. Appl. Environ. Microbiol. 77:8164-8170.
45. Monedero V, Kuipers OP, Jamet E, Deutscher J. 2001. Regulatory functions of serine-46-phosphorylated HPr in Lactococcus lactis. J. Bacteriol. 183:3391-3398. (Pubitemid 32448603)
46. Nes IF, Yoon SS, Diep DB. 2007. Ribosomally synthesized antimicrobial peptides (bacteriocins) in lactic acid bacteria: a review. Food Sci. Biotechnol. 16:675- 690.
47. Nilsson U, Radstrom P. 2001. Genetic localization and regulation of the maltose phosphorylase gene, malP, in Lactococcus lactis. Microbiology 147:1565-1573. (Pubitemid 32544821)
48. Opsata M, Nes IF, Holo H. 2010. Class IIa bacteriocin resistance in Enterococcus faecalis V583: the mannose PTS operon mediates global transcriptional responses. BMC Microbiol. 10:224.
49. Qian N, Stanley GA, Bunte A, Radstrom P. 1997. Product formation and phosphoglucomutase activities in Lactococcus lactis: cloning and characterization of a novel phosphoglucomutase gene. Microbiology 143(Pt 3): 855-865. (Pubitemid 27192763)
50. Rademaker JL, et al. 2007. Diversity analysis of dairy and nondairy Lactococcus lactis isolates, using a novel multilocus sequence analysis scheme and (GTG)5-PCR fingerprinting. Appl. Environ. Microbiol. 73:7128-7137. (Pubitemid 350196659)
51. Sambrook J, Russell DW. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
52. Sanchez J, et al. 2007. Antimicrobial and safety aspects, and biotechnological potential of bacteriocinogenic enterococci isolated from mallard ducks (Anas platyrhynchos). Int. J. Food Microbiol. 117:295-305. (Pubitemid 46977481)
53. Sawa N, et al. 2009. Identification and characterization of lactocyclicin Q, a novel cyclic bacteriocin produced by Lactococcus sp. strain QU 12. Appl. Environ. Microbiol. 75:1552-1558.
54. Sjoberg A, Hahn-Hagerdal B. 1989. Beta-glucose-1-phosphate, a possible mediator for polysaccharide formation in maltose-assimilating Lactococcus lactis. Appl. Environ. Microbiol. 55:1549-1554. (Pubitemid 19155080)
55. Tagg JR, Dajani AS, Wannamaker LW. 1976. Bacteriocins of gram-positive bacteria. Bacteriol. Rev. 40:722-756.
56. Thennarasu S, et al. 2005. Membrane permeabilization, orientation, and antimicrobial mechanism of subtilosin A. Chem. Phys. Lipids 137: 38 -51.
57. van Belkum MJ, Martin-Visscher LA, Vederas JC. 2011. Structure and genetics of circular bacteriocins. Trends Microbiol. 19:411-418.
58. Wiedemann I, et al. 2006. The mode of action of the lantibiotic lacticin 3147-a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol. Microbiol. 61: 285-296. (Pubitemid 44356563)
59. Wiedemann I, et al. 2001. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276: 1772-1779. (Pubitemid 32109649)
60. Wirawan RE, Swanson KM, Kleffmann T, Jack RW, Tagg JR. 2007. Uberolysin: a novel cyclic bacteriocin produced by Streptococcus uberis. Microbiology 153:1619 -1630.